Xenon制药

$Xenon制药(XENE)$ 的Azetukalner与$Biohaven(BHVN)$ 的BHV-7000即将在2026年公布钾离子激动剂的关键数据。这两款药物均是在第一代药物Ezogabine基础上优化了选择性和药代动力学。其中，Opakalim不结合GABA受体，相比Azatukalner降低GABA相关的副作用如嗜睡和头痛等。
从已公布的早期临床数据...

$Praxis(PRAX)$ 管线四个药
Ulixacaltamide (PRAX-944)（震颤成功，但安全性差点意思）
Vormatrigine (PRAX-628)（虽然数据比隔壁的$Xenon制药$Xenon制药(XENE)$ 略好，但单臂，差点意思）
Relutrigine (PRAX-562)（罕见癫痫病，目前数据也不差）
Elsunersen (PRAX-222)（早期，预...

$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-313147  Size: 10 KB 网页链接

$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-009230  Size: 7 KB 网页链接

$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-009235  Size: 7 KB 网页链接

$Xenon制药(XENE)$ 144 Report of proposed sale of securities Accession Number: 0001193125-26-001168  Act: 33  Size: 6 KB 网页链接

$Xenon制药(XENE)$ 144 Report of proposed sale of securities Accession Number: 0001193125-25-304226  Act: 33  Size: 5 KB 网页链接

$Xenon制药(XENE)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-25-303862  Act: 34  Size: 741 KB 网页链接

$Xenon制药(XENE)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-25-303888  Act: 33  Size: 457 KB 网页链接

$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-307211  Size: 5 KB 网页链接

$Xenon制药(XENE)$ 144 Report of proposed sale of securities Accession Number: 0001193125-25-311409  Act: 33  Size: 7 KB 网页链接

$Xenon制药(XENE)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001274173-25-000274  Act: 34  Size: 9 KB 网页链接

$Xenon制药(XENE)$ 144 Report of proposed sale of securities Accession Number: 0001193125-25-310009  Act: 33  Size: 5 KB 网页链接

$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-009232  Size: 7 KB 网页链接

$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-009238  Size: 7 KB 网页链接

$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-001172  Size: 11 KB 网页链接